| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Regeneron's focus on product development is exemplified by their advancements in therapies like TSRA-196 and continued progress in gene-editing collaborations. The company's success in experimental cancer treatments further emphasizes their commitment to healthcare innovation. Notably, the optimism surrounding the potential for clinical trials suggests a promising future for novel therapies. Overall, Regeneron is actively shaping advancements in the pharmaceutical landscape. |
| The price action of Regeneron Pharmaceuticals (REGN) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at -0.6 is bearish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for REGN since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.3, and the negative at -0.3 on 2025-12-06. The forces of Valuation Sentiment (-0.8), Stock Price Trend (-0.6), and Market Risk Appetite (-0.3) will drive down the price. The forces of Price Level Sentiment (0), Option Sentiment (0), Sector Price Trend (0.2), and Sentiment towards Fundamentals (1.9) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| REGN | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-06 | 0%(0%) | -0.6 | -0.17% | 0.1 | 1.9 | -1 | |||||||
| 2025-12-05 | 0%(0%) | 718.36 | 47 | -0.61% | -0.25% | -0.6 | -0.17% | 0.6% | 0.2 | Short | 65% | 1.4 | -1 |
| 2025-12-04 | 0%(0%) | 722.8 | 52 | -0.12% | 0.27% | 0 | 0% | 1.1% | 0.5 | Wait | 50% | 2 | -1 |
| 2025-12-03 | 0%(0%) | 723.67 | 55 | -2.47% | -0.03% | -0.2 | -0.05% | 1.1% | 0.6 | Short | 60% | 2.6 | -1 |
| 2025-12-02 | 0%(0%) | 742 | 66 | -1.08% | 0.51% | 0.5 | 0.13% | 0.6% | 0.5 | Long | 65% | 2.1 | -1 |
| 2025-12-01 | 0%(0%) | 750.11 | 72 | -3.86% | 0.77% | 0.5 | 0.13% | 0.5% | 0.3 | Long | 65% | 2.1 | -1 |
| 2025-11-30 | 0%(0%) | 1 | 0.25% | 0.5 | 2.4 | -1 | |||||||
| 2025-11-29 | 0%(0%) | 1 | 0.25% | 0.6 | 2 | -1 | |||||||
| 2025-11-28 | 0%(0%) | 780.19 | 89 | -0.56% | 1.16% | 1.7 | 0.43% | 0.5% | 1 | Long | 60% | 2 | -1 |
| 2025-11-27 | 0%(0%) | 1 | 0.25% | 0.7 | 2.2 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-12-06 17:05:49 There is a growing focus in the medical community on developing effective treatments for blood cancers, supported by recent trial results. |
| 2025-12-06 17:05:49 The positive trial results may enhance the chances of regulatory approval for the new therapy. |
| 2025-12-06 17:05:49 The successful outcomes from this therapy may attract investments and interest in innovative cancer treatment solutions. |
| 2025-12-06 17:05:49 The results from the late-stage trial suggest a positive trend in the success of clinical trials for cancer therapies. |
| 2025-12-06 17:05:49 The effectiveness of the experimental cancer combination therapy indicates significant advancements in treatment options for cancer patients. |